Browse Studies — Arctuva

Phase 1

Intravenous Acetate as an Adjunctive Treatment for Alcohol Withdrawal in Hospitalized Patients

Alcohol withdrawal syndrome is a highly morbid condition affecting a substantial percentage of patients hospitalized who have alcohol use disorders, estimated …

Alcohol WithdrawalAlcohol AbstinenceAlcohol Use Disorder

Estimated

~$10 – $6,250

University of Colorado, DenverNCT07810946

Phase 2

Prazosin Treatment for Alcohol Use Disorder With Alcohol Withdrawal Symptoms

This is a Phase 2 single site randomized clinical trial (RCT) to be supported by a new NIH-NIAAA grant, R01-AA029113-01, to assess the efficacy of Prazosin (16…

Alcohol Withdrawal

Estimated

~$10 – $6,250

Yale UniversityNCT04793685

Phase 2

Effects of Ketone Supplementation on Alcohol Withdrawal and Brain Metabolism in Alcohol Use Disorder

The goal of this clinical trial is to learn the effects of ketone supplement compared to placebo on alcohol withdrawal symptoms during a 4 day alcohol withdraw…

Alcohol Use DisorderAlcohol WithdrawalKetosis

Estimated

~$10 – $6,250

University of PennsylvaniaNCT06559995

Observational

The Use of Non-invasive Transcutaneous Auricular Neurostimulation (tAN®) in Alcohol Withdrawal Management

This research study is being conducted to learn if Transcutaneous Auricular Neurostimulation (tAN®) may be effective in treating alcohol withdrawal syndrome. T…

Alcohol Withdrawal

Estimated

~$10 – $7,500

Erin DenekeNCT06771037